Onc Now
In this episode of Onc Now, Michael Cecchini, Associate Professor of Medicine at Yale School of Medicine, New Haven, Connecticut, USA, discusses his journey into gastrointestinal oncology and the evolution of care for patients with colorectal and rectal cancers. From the complexities of multidisciplinary coordination to the promise of early-phase clinical trials, Cecchini reflects on how molecular profiling and next-generation systemic therapies are reshaping treatment paradigms.
Apple | Spotify | Amazon Music | Youtube (36 mins)
Speaker bio:
Michael Cecchini is Associate Professor of Medicine in Medical Oncology at Yale School of Medicine, New Haven, Connecticut, USA. He serves as Co-Director of the Colorectal Program within the Center for Gastrointestinal Cancers and is Medical Oncology Section Lead for the National Accreditation Program for Rectal Cancer within Internal Medicine. In addition, he is a Phase 1 Investigator at Yale Cancer Center and Director of the GI Clinical Research Team at the Yale Center for GI Cancers. Michael Cecchini is widely recognised for his expertise in gastrointestinal malignancies, with a particular focus on colorectal and rectal cancers.
Timestamps:
00:00 – Introduction
01:13 – Path to gastrointestinal oncology
03:00 – Multidisciplinary care challenges
07:20 – Early phase trial advances
11:26 – Evolving systemic therapies
14:58 – Impact of molecular profiling
20:20 – Translating trials to practice
23:38 – Advice for clinician investigators
28:21 – Future therapeutic advances
31:50 – Three wishes for gastrointestinal care
Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.
